Experience

ANFARM

• Greece
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Business Development & Licensing Director

  • Sep 2016 - Present

  ANFARM is one of Greece’s leading EU GMP manufacturers of lyophilized products, β-lactams and injectable pharmaceutical products. The company has a global export activity, both through direct exports and by manufacturing products for other companies. ANFARM’s in-house developed products are registered and/or licensed out in various European countries, in Canada, Australia and South Africa and also in emerging generic markets such as the MENA, LATAM and APAC regions. Over the past 52 years ANFARM has been established as a dynamic manufacturer of pharmaceutical products and a valued partner for multinational companies. The secret behind its success has always been its dedication to its people, its partners, the quality of its products and its continuous investment is research, technology and manufacturing facilities We welcome BD&L inquiries related to:  Licensing Out of Lyophilized products, Cephalosporins, Carbapenems, other sterile and non-sterile products,  Contract Manufacturing  Product Development Services Show less



Win Medica Pharmaceutical SA

• Greece
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Key Account & Innovation Manager

  • Jan 2015 - Aug 2016

  Responsible for identifying and developing new & innovative projects mainly in oncology, hematology, endocrinology, antibiotics, CVS, GI & renal disease for novel and biosimilar pharmaceuticals. Acting Marketing Liaison between Business Development and Marketing Developing and establishing relationships with KOLs, physicians, patient organizations & health stakeholders. Responsible for identifying and developing new & innovative projects mainly in oncology, hematology, endocrinology, antibiotics, CVS, GI & renal disease for novel and biosimilar pharmaceuticals. Acting Marketing Liaison between Business Development and Marketing Developing and establishing relationships with KOLs, physicians, patient organizations & health stakeholders.



Elpen Pharmaceutical Co. Inc.

• Greece
• Pharmaceutical Manufacturing
• 400 - 500 Employee

• Corporate Development & Licencing Manager

  • Jun 2010 - Dec 2014

  Responsible for developing and managing Elpen Group’s (Elpen, Aenorasis & WinMedica) partner relationships. Identification of novel & biosimilar product candidates across all therapeutic areas, with a main focus in oncology/haematology, renal disease, CNS, antibiotics and diabetes. Responsible for the design and implementation of Elpen’s expansion strategy in Europe (Balkans, CEE, Baltics & Nordics). Responsible for developing and managing Elpen Group’s (Elpen, Aenorasis & WinMedica) partner relationships. Identification of novel & biosimilar product candidates across all therapeutic areas, with a main focus in oncology/haematology, renal disease, CNS, antibiotics and diabetes. Responsible for the design and implementation of Elpen’s expansion strategy in Europe (Balkans, CEE, Baltics & Nordics).



Aenorasis S.A.

• Greece
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Business Development Director

  • Jan 2009 - Jun 2010

  Identification of new product candidates, new product lines and companies for the South-eastern European markets, due diligence and market potential evaluation, clinical & regulatory information evaluation, contract negotiations & drafting, in-licensing, representation of the company in BD and investor conferences, building and maintaining strong relationships with the new and potential partners and the management of inter-company departments’ (marketing, sales, regulatory) relations towards the establishment of new partnerships. Responsible for the setup of the company’s presence in Cyprus and The Balkans, Exports, and Corporate Affairs (the management of the corporate image of the company through the creation & management of its website). Show less



GENESIS Pharma

• Greece
• Pharmaceutical Manufacturing
• 100 - 200 Employee

• Business Development Manager

  • Jun 2003 - Dec 2008

  Identification of new product candidates, new product lines and companies for the South-eastern European markets, due diligence and market potential evaluation, clinical & regulatory information evaluation, contract negotiations & drafting, in-licensing, representation of the company in BD and investor conferences, building and maintaining strong relationships with the new and potential partners and the management of inter-company departments’ (marketing, sales, regulatory, medical affairs) relations towards the establishment of new partnerships. My duties also included involvement in corporate affairs, i.e. the management of the corporate image of the company through the creation & management of its website. Show less



PwC

• Professional Services
• 700 & Above Employee

• Senior Consultant

  • Mar 2001 - Jun 2003

  Global Risk Management Services: IT Risk Management team, audit services on the IT functions of Philip Morris, Sfakianakis- Suzuki, Bacardi Hellas. Project Management Office of the IT Implementation of Credicom: PM of IT implementation, supervision based on Contract Documents and project plans, process/ progress of the implementation and the User Acceptance Test strategy, UAT workshops. Organizational design for the Agricultural Bank of Poland: Analysis of comparators following criteria from a wide regional network of commercial banks for the identification of major European agricultural banks, similarities and differences in organizational structures and identification of business strategies and alliances. Business plan for the Hellenic Ministry of Public Order: Analysis of internal and external environment for the evaluation of the interactions between the Ministry and the 3rd European Financial Framework, development and business planning of Information and Communication Technologies in order to offer the best possible services to the citizens, development of action plans in order to serve the business plan goals. Activity Based Costing/Benchmarking project for the Hellenic Postal Organization: Research and analysis of postal statistics, interpretation of statistical and financial indices for the European Post Offices, delivery of the final report’s section on international benchmarking, esearch and analysis of postal statistics and nterpretation of statistical and financial data and ratios for the European Post Offices. Global PwC Financial Systems SAP Project: Implementation of Financials and Controlling modules, full integration of the GL sub-module through SAP R/3, by mirroring its direct connection with controlling, asset management, accounts payable and receivable, sales, projects and HR modules and sub-modules. Participated in the Implementation, Go Live and Support Phases of both FI and CO modules. Show less



Citi

• United States
• Financial Services
• 700 & Above Employee

• CitiGold Executive

  • 2000 - 2001

  Analysis of high profile customers’ financials, with an over $200,000 relationship with the bank, updates on market trends, investment risks based on preferred tolerance, forming of successful portfolios based on investment profiles by offering the best possible solutions, follow up and keeping customer relations management throughout the investment progress. Analysis of high profile customers’ financials, with an over $200,000 relationship with the bank, updates on market trends, investment risks based on preferred tolerance, forming of successful portfolios based on investment profiles by offering the best possible solutions, follow up and keeping customer relations management throughout the investment progress.



Scripps Research

• United States
• Research Services
• 700 & Above Employee

• Visiting Scientist

  • Jul 1999 - Oct 1999

  Prof. KC Nicolaou's team working on the total organic synthesis of the epothylone groups, stage 1 testing (LD50) of potential anti-cancer agents, and preparation of presentations and scientific papers Prof. KC Nicolaou's team working on the total organic synthesis of the epothylone groups, stage 1 testing (LD50) of potential anti-cancer agents, and preparation of presentations and scientific papers